The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Radiopharmaceutical-Global Market Insights and Sales Trends 2025
Synopsis
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global Radiopharmaceutical market size is expected to reach US$ 11660 million by 2029, growing at a CAGR of 8.0% from 2023 to 2029. The market is mainly driven by the significant applications of Radiopharmaceutical in various end use industries. The expanding demands from the Oncology, Cardiology and Other, are propelling Radiopharmaceutical market. Actinium-225, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lutetium-177 segment is estimated at % CAGR for the next seven-year period.
The global Radiopharmaceutical top three manufacturers include the Bracco Imaging, Bayer and Mallinckrodt, with about 47% market shares. North America and Europe is the main consumption places, with a consumption market share nearly 45% and 27%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Radiopharmaceutical, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Radiopharmaceutical market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Radiopharmaceutical market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Radiopharmaceutical sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Radiopharmaceutical covered in this report include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc.
The global Radiopharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Global Radiopharmaceutical market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Radiopharmaceutical market, Segment by Type:
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Global Radiopharmaceutical market, by Application
Oncology
Cardiology
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Radiopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global Radiopharmaceutical market size is expected to reach US$ 11660 million by 2029, growing at a CAGR of 8.0% from 2023 to 2029. The market is mainly driven by the significant applications of Radiopharmaceutical in various end use industries. The expanding demands from the Oncology, Cardiology and Other, are propelling Radiopharmaceutical market. Actinium-225, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lutetium-177 segment is estimated at % CAGR for the next seven-year period.
The global Radiopharmaceutical top three manufacturers include the Bracco Imaging, Bayer and Mallinckrodt, with about 47% market shares. North America and Europe is the main consumption places, with a consumption market share nearly 45% and 27%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Radiopharmaceutical, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Radiopharmaceutical market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Radiopharmaceutical market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Radiopharmaceutical sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Radiopharmaceutical covered in this report include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc.
The global Radiopharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Global Radiopharmaceutical market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Radiopharmaceutical market, Segment by Type:
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Global Radiopharmaceutical market, by Application
Oncology
Cardiology
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Radiopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Radiopharmaceutical Market Overview
1.1 Radiopharmaceutical Product Overview
1.2 Radiopharmaceutical Market Segment by Type
1.2.1 Actinium-225
1.2.2 Lutetium-177
1.2.3 Radium-223
1.2.4 Holmium-166
1.2.5 Other
1.3 Global Radiopharmaceutical Market Size by Type
1.3.1 Global Radiopharmaceutical Market Size Overview by Type (2018-2029)
1.3.2 Global Radiopharmaceutical Historic Market Size Review by Type (2018-2023)
1.3.3 Global Radiopharmaceutical Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Radiopharmaceutical Sales Breakdown by Type (2018-2023)
1.4.2 Europe Radiopharmaceutical Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Radiopharmaceutical Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Radiopharmaceutical Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Radiopharmaceutical Sales Breakdown by Type (2018-2023)
2 Global Radiopharmaceutical Market Competition by Company
2.1 Global Top Players by Radiopharmaceutical Sales (2018-2023)
2.2 Global Top Players by Radiopharmaceutical Revenue (2018-2023)
2.3 Global Top Players by Radiopharmaceutical Price (2018-2023)
2.4 Global Top Manufacturers Radiopharmaceutical Manufacturing Base Distribution, Sales Area, Product Type
2.5 Radiopharmaceutical Market Competitive Situation and Trends
2.5.1 Radiopharmaceutical Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Radiopharmaceutical Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2022)
2.7 Date of Key Manufacturers Enter into Radiopharmaceutical Market
2.8 Key Manufacturers Radiopharmaceutical Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Radiopharmaceutical Status and Outlook by Region
3.1 Global Radiopharmaceutical Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Radiopharmaceutical Historic Market Size by Region
3.2.1 Global Radiopharmaceutical Sales in Volume by Region (2018-2023)
3.2.2 Global Radiopharmaceutical Sales in Value by Region (2018-2023)
3.2.3 Global Radiopharmaceutical Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Radiopharmaceutical Forecasted Market Size by Region
3.3.1 Global Radiopharmaceutical Sales in Volume by Region (2024-2029)
3.3.2 Global Radiopharmaceutical Sales in Value by Region (2024-2029)
3.3.3 Global Radiopharmaceutical Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Radiopharmaceutical by Application
4.1 Radiopharmaceutical Market Segment by Application
4.1.1 Oncology
4.1.2 Cardiology
4.1.3 Other
4.2 Global Radiopharmaceutical Market Size by Application
4.2.1 Global Radiopharmaceutical Market Size Overview by Application (2018-2029)
4.2.2 Global Radiopharmaceutical Historic Market Size Review by Application (2018-2023)
4.2.3 Global Radiopharmaceutical Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Radiopharmaceutical Sales Breakdown by Application (2018-2023)
4.3.2 Europe Radiopharmaceutical Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Radiopharmaceutical Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Radiopharmaceutical Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Radiopharmaceutical Sales Breakdown by Application (2018-2023)
5 North America Radiopharmaceutical by Country
5.1 North America Radiopharmaceutical Historic Market Size by Country
5.1.1 North America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Radiopharmaceutical Sales in Volume by Country (2018-2023)
5.1.3 North America Radiopharmaceutical Sales in Value by Country (2018-2023)
5.2 North America Radiopharmaceutical Forecasted Market Size by Country
5.2.1 North America Radiopharmaceutical Sales in Volume by Country (2024-2029)
5.2.2 North America Radiopharmaceutical Sales in Value by Country (2024-2029)
6 Europe Radiopharmaceutical by Country
6.1 Europe Radiopharmaceutical Historic Market Size by Country
6.1.1 Europe Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Radiopharmaceutical Sales in Volume by Country (2018-2023)
6.1.3 Europe Radiopharmaceutical Sales in Value by Country (2018-2023)
6.2 Europe Radiopharmaceutical Forecasted Market Size by Country
6.2.1 Europe Radiopharmaceutical Sales in Volume by Country (2024-2029)
6.2.2 Europe Radiopharmaceutical Sales in Value by Country (2024-2029)
7 Asia-Pacific Radiopharmaceutical by Region
7.1 Asia-Pacific Radiopharmaceutical Historic Market Size by Region
7.1.1 Asia-Pacific Radiopharmaceutical Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Radiopharmaceutical Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Radiopharmaceutical Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Radiopharmaceutical Forecasted Market Size by Region
7.2.1 Asia-Pacific Radiopharmaceutical Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Radiopharmaceutical Sales in Value by Region (2024-2029)
8 Latin America Radiopharmaceutical by Country
8.1 Latin America Radiopharmaceutical Historic Market Size by Country
8.1.1 Latin America Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Radiopharmaceutical Sales in Volume by Country (2018-2023)
8.1.3 Latin America Radiopharmaceutical Sales in Value by Country (2018-2023)
8.2 Latin America Radiopharmaceutical Forecasted Market Size by Country
8.2.1 Latin America Radiopharmaceutical Sales in Volume by Country (2024-2029)
8.2.2 Latin America Radiopharmaceutical Sales in Value by Country (2024-2029)
9 Middle East and Africa Radiopharmaceutical by Country
9.1 Middle East and Africa Radiopharmaceutical Historic Market Size by Country
9.1.1 Middle East and Africa Radiopharmaceutical Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Radiopharmaceutical Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Radiopharmaceutical Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Radiopharmaceutical Forecasted Market Size by Country
9.2.1 Middle East and Africa Radiopharmaceutical Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Radiopharmaceutical Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bracco Imaging
10.1.1 Bracco Imaging Company Information
10.1.2 Bracco Imaging Introduction and Business Overview
10.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bracco Imaging Radiopharmaceutical Products Offered
10.1.5 Bracco Imaging Recent Development
10.2 Bayer
10.2.1 Bayer Company Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bayer Radiopharmaceutical Products Offered
10.2.5 Bayer Recent Development
10.3 Mallinckrodt
10.3.1 Mallinckrodt Company Information
10.3.2 Mallinckrodt Introduction and Business Overview
10.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mallinckrodt Radiopharmaceutical Products Offered
10.3.5 Mallinckrodt Recent Development
10.4 Nordion
10.4.1 Nordion Company Information
10.4.2 Nordion Introduction and Business Overview
10.4.3 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Nordion Radiopharmaceutical Products Offered
10.4.5 Nordion Recent Development
10.5 Triad Isotopes
10.5.1 Triad Isotopes Company Information
10.5.2 Triad Isotopes Introduction and Business Overview
10.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Triad Isotopes Radiopharmaceutical Products Offered
10.5.5 Triad Isotopes Recent Development
10.6 Lantheus
10.6.1 Lantheus Company Information
10.6.2 Lantheus Introduction and Business Overview
10.6.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Lantheus Radiopharmaceutical Products Offered
10.6.5 Lantheus Recent Development
10.7 IBA Group
10.7.1 IBA Group Company Information
10.7.2 IBA Group Introduction and Business Overview
10.7.3 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
10.7.4 IBA Group Radiopharmaceutical Products Offered
10.7.5 IBA Group Recent Development
10.8 GE Healthcare
10.8.1 GE Healthcare Company Information
10.8.2 GE Healthcare Introduction and Business Overview
10.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
10.8.4 GE Healthcare Radiopharmaceutical Products Offered
10.8.5 GE Healthcare Recent Development
10.9 China Isotope & Radiation
10.9.1 China Isotope & Radiation Company Information
10.9.2 China Isotope & Radiation Introduction and Business Overview
10.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
10.9.4 China Isotope & Radiation Radiopharmaceutical Products Offered
10.9.5 China Isotope & Radiation Recent Development
10.10 Jubilant Pharma
10.10.1 Jubilant Pharma Company Information
10.10.2 Jubilant Pharma Introduction and Business Overview
10.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Jubilant Pharma Radiopharmaceutical Products Offered
10.10.5 Jubilant Pharma Recent Development
10.11 Eli Lilly
10.11.1 Eli Lilly Company Information
10.11.2 Eli Lilly Introduction and Business Overview
10.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Eli Lilly Radiopharmaceutical Products Offered
10.11.5 Eli Lilly Recent Development
10.12 Advanced Accelerator Applications
10.12.1 Advanced Accelerator Applications Company Information
10.12.2 Advanced Accelerator Applications Introduction and Business Overview
10.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Advanced Accelerator Applications Radiopharmaceutical Products Offered
10.12.5 Advanced Accelerator Applications Recent Development
10.13 SIEMENS
10.13.1 SIEMENS Company Information
10.13.2 SIEMENS Introduction and Business Overview
10.13.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
10.13.4 SIEMENS Radiopharmaceutical Products Offered
10.13.5 SIEMENS Recent Development
10.14 Dongcheng
10.14.1 Dongcheng Company Information
10.14.2 Dongcheng Introduction and Business Overview
10.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Dongcheng Radiopharmaceutical Products Offered
10.14.5 Dongcheng Recent Development
10.15 Navidea
10.15.1 Navidea Company Information
10.15.2 Navidea Introduction and Business Overview
10.15.3 Navidea Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Navidea Radiopharmaceutical Products Offered
10.15.5 Navidea Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Radiopharmaceutical Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Radiopharmaceutical Industrial Chain Analysis
11.4 Radiopharmaceutical Market Dynamics
11.4.1 Radiopharmaceutical Industry Trends
11.4.2 Radiopharmaceutical Market Drivers
11.4.3 Radiopharmaceutical Market Challenges
11.4.4 Radiopharmaceutical Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Radiopharmaceutical Distributors
12.3 Radiopharmaceutical Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
